Pediatric Neuroimaging Findings and Clinical Presentations of COVID-19: A Systematic Review

Since March 2020, there have been more than 770 million confirmed cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) infection, according to the World Health Organization [1]. SARS-CoV-2 infection usually leads to milder symptoms in children, but about 34% develop a unique life-threatening condition known as Multisystem Inflammatory Syndrome in Children (MIS-C), Pediatric Inflammatory Multisystem Syndrome Temporally associated with COVID-19 (PIMS-TS), Systemic inflammatory syndrome in COVID-19 (SISCoV), and COVID-19-associated Kawasaki-like multisystem inflammatory syndrome (Kawa-COVID-19) 4-6 weeks after infection [2 –4].
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research